DaVita(DVA)
Search documents
3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN
ZACKS· 2024-09-13 15:16
When stocks are cruising at or nearing all-time highs, it reflects considerable bullishness with trends where buyers are in control. Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are rolling in. That's been precisely the case for Intuitive Surgical (ISRG) , SharkNinja (SN) , and DaVita (DVA) , all of which presently sport a favorable Zacks Rank and are trading near 52-week highs. Let's take a closer look at what's been driving the bu ...
DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?
ZACKS· 2024-09-13 14:16
Have you been paying attention to shares of DaVita HealthCare (DVA) ? Shares have been on the move with the stock up 5.1% over the past month. The stock hit a new 52-week high of $160.82 in the previous session. DaVita HealthCare has gained 50.5% since the start of the year compared to the 11.1% move for the Zacks Medical sector and the 17.5% return for the Zacks Medical - Outpatient and Home Healthcare industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surp ...
DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role
Prnewswire· 2024-09-13 12:00
DENVER, Sept. 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that David Maughan will assume the role of chief operating officer. This appointment builds on Maughan's 18- year tenure at DaVita in a range of leadership roles. After a celebrated 11-year tenure as chief operating officer, Mike Staffieri will step into the role of chief operating officer emeritus. Both appointments are effective September 15, 2024. Dave Maughan, chief operations officer for DaVitaDav ...
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2024-09-10 17:01
DaVita HealthCare (DVA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. The power of a ...
DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue?
ZACKS· 2024-09-05 16:36
It has been about a month since the last earnings report for DaVita HealthCare (DVA) . Shares have added about 13% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is DaVita HealthCare due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. DaVita Q2 Earnings & Revenues Top Es ...
DaVita Rallies 44% Year to Date: What's Driving the Stock?
ZACKS· 2024-09-02 14:21
DaVita (DVA) has witnessed strong momentum year to date, with its shares up 44% compared with the industry growth of 17.9%. The S&P 500 composite has risen 18.4% in the year-to-date period. DaVita, carrying a Zacks Rank #1 (Strong Buy) at present, is witnessing an upward trend in its stock price, prompted by the company's business model. The optimism, led by a solid second-quarter 2024 performance and the acquisition of dialysis centers, is expected to contribute further. Denver, CO-headquartered DaVita, is ...
DaVita HealthCare (DVA) is a Great Momentum Stock: Should You Buy?
ZACKS· 2024-08-30 17:01
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Eve ...
3 Defensive Stocks Outperforming in a Choppy Market (PM, DVA, STWD)
ZACKS· 2024-08-28 20:51
Broad markets, although continuing to trend higher, are showing signs of increasing volatility and uncertainty. While there has been a strong rally in stocks since the sharp correction earlier in the month, there is something peculiar happening under the surface. Defensive sectors and stocks are making new highs, while the former leaders hover below. While I have long been encouraging investors join in the mega cap technology and artificial intelligence rally for the long-term, I also noted that the period ...
2 Must-Buy Medical Stocks With Strong Momentum
ZACKS· 2024-08-28 13:06
Wall Street has been maintaining its northbound journey in the second half of 2024 after an impressive first half. U.S. stock markets' rally, which started at the beginning of 2023 is showing no signs of declining barring some minor fluctuations. The rally is likely to gather pace over the remaining months this year as an interest rate cut in September is now almost certain. Under this circumstance, it should be prudent for investors to put money in those stocks with strong momentum. Here we are recommendin ...
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?
ZACKS· 2024-08-15 14:16
Have you been paying attention to shares of DaVita HealthCare (DVA) ? Shares have been on the move with the stock up 6.6% over the past month. The stock hit a new 52-week high of $151.05 in the previous session. DaVita HealthCare has gained 42.1% since the start of the year compared to the 8.6% move for the Zacks Medical sector and the 11.4% return for the Zacks Medical - Outpatient and Home Healthcare industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surpr ...